Kala-azar - New developments in diagnosis and treatment

Indian Journal of Pediatrics

Volumn 66, Issue 1, 1999, Pages 63-71

  Aggarwal, Praveen ^a   Handa, Rohini ^a   Singh, Sarman ^a   Wali, Jyoti Prakash ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Direct aggluatination test; Kala azar; Pentavalent antimony; Visceral leishmaniasis

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY DERIVATIVE; FLUCONAZOLE; GAMMA INTERFERON; IMIDAZOLE DERIVATIVE; ISONIAZID; KETOCONAZOLE; LIPOSOME; PAROMOMYCIN; PENTAMIDINE; RIFAMPICIN; SITAMAQUINE; STIBOGLUCONATE SODIUM;

ANTIGEN DETECTION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG RESISTANCE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LEISHMANIASIS; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SIDE EFFECT; VISCERAL LEISHMANIASIS;

EID: 0033044744     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02752355     Document Type: Conference Paper

References (28)

1. Kager PA. Visceral leishmaniasis. Curr Opinions Infect Dis 1988; 1 : 700-703.
2. Allain DS, Kagan IG. A direct agglutination test for leishmaniasis. Am J Trop Med Hyg 1975; 24 : 232-236.
3. Harith AE, Kolk AH, Leewenburg J et al. Improvement of a direct agglutination test for field studies of visceral leishmaniasis. J Clin Immunol 1988; 26 : 1321-1325.
4. Singla N, Singh S, Sunder S, Vinayak VK. Evaluation of the direct agglutination test as an immunodiagnostic tool for kalaazar in India. Trans R Soc Trop Med Hyg 1993; 87 : 276-279.
5. Singh S, Gilman-Sachs A, Chang KP, Reed SG. Diagnostic and prognostic value of k39 recombinant antigen in Indian leishmaniasis. J Parasitol 1995; 81 : 1000-1003.
6. Sinha R. Sehgal S. Comparative evaluation of serological tests in Indian kalaazar. J Trop Med Hyg 1994; 97 : 334-340.
7. Jha TK, Thakur CPN, Singh IJ, Jha S. Direct agglutination test for early diagnosis of Indian visceral leishmaniasis. J Assoc Physicians India 1996; 44 : 606-608.
8. Chaudhry A, Guru PY, Saxena RP, Tandon A, Saxena KC. Enzyme linked immunosorbent assay in the diagnosis of kalaazar in Bhadohi (Varanasi), India. Trans R Soc Trop Med Hyg 1990; 84 : 363-366.
9. Vinayak VK, Mahajan D, Sobti RC, Singla N, Sunder S. Anti-66 kDa anti-leishmanial antibodies as specific immunodiganostic probe for vsiceral leishmaniasis. Indian J Med Res 1994; 99 : 109-114.
10. Pappas MG, Hajkowski R, Hockmeyer WT. Standardization of the Dot enzyme-linked immunosorbent assay (Dot-ELISA) for human visceral leishmaniasis. Am J Trop Med Hyg 1993; 33 : 1105-1111.
11. Gupta S, Srivastava JK, Pal A. et al. Direct agglutination test and Dot-ELISA in the serodiagnosis of visceral leishmaniasis (kala-azar) - a comparative study. Serodiag Immunother Infect Dis 1994; 6 : 154-158
12. Agarwal M, Jain A, Tewari V Comparative evaluation of serological tests for diagnosis of visceral leishmaniasis. Indian J Exp Biol 1996; 34 : 734-738.
13. Sinha R, Arora SK, Sehgal S. A sensitive ELISA for detection of circulating antigens in kala-azar patients. Indian J Med Res 1988; 88 : 138-140.
14. Senaldi G, Xiao-su H, Hoessli DC, Bordier C. Serological diagnosis of visceral leishmaniasis by dot-enzyme immunoassay for the detection of a Leishmania donovani-related circulating antigen. J Immunol Medhods 1996; 193 : 9-15.
15. de-Colmenares M, Portus M, Rier C, et al Detection of 72-75 kD and 123 kD fractions of Leishmania antigen in urine of patients with visceral leishmaniasis. Am J Trop Med Parasitol 1995; 52 : 427-428.
16. Piarroux R, Gambarelli F, Dumon H, et al. Comparison of PCR with direct examination of bone marrow aspiration, myeloculture and serology for diagnosis of visceral leishmaniasis in immunocompromised-patients. J Clin Microbiol 1994; 32 : 746-749.
17. H, a 9-O-acetylated sialic acid binding lectin. Am J Trop Med Hyg 1998; 58 : 551-554.
18. Aggarwal P, Wali JP. Profile of kala-azar in north India Asia Pacific J Pub Health 1991; 5 : 90-93.
19. Sunder S, Rosenkaimer F, Murray HW. Immunochemotherapy for a systemic intracellular infection. Accelerated response using interferon-gamma in visceral leishmaniasis. J Infect Dis 1995; 171 : 992-996.
20. Herwaldt BL, Berman JD Recommendations for treating leishmaniasis with sodium stibogluconate (pentosam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992; 46 : 296-306.
21. Davidson RN, Croft SL, Scott A, Maini M, Moody AH, Bryceson ADM. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet 1991; 337 1061-1062
22. Dietze R, Milan EP, Berman JD, et al. Treatment of Brazilian kala-azar with a short course Amphocil (amphotericin B cholesterol dispersion). Clin Infect Dis 1993, 17 : 981-986
23. Sunder S, Murray HW. Cure of antimony-unresponsive Indian visceral leishmaniasis with liposomal amphotericin B lipid complex. J Infect Dis 1996; 173 : 762-765.
24. ®) for visceral leishmaniasis in India : a randomized dose-finding study. Trans R Soc Trop Med Hyg 1996, 90 : 319-322.
25. Thakur CP, Bhowmick S, Dolfi L, Olliaro P Aminosidine plus sodium stibogluconate for the treatment of Indian kalaazar : a randomized dose-finding clinical trial. Trans R Soc Trop Med Hyg 1995, 89 : 219-223.
26. Wali JP, Aggarwal P, Gupta U, Saluja S, Singh S Ketoconazole in treatment of visceral leishmaniasis Lancet 1990, 330 : 810-811.
27. Wali JP, Aggarwal P, Nandy A, et al. Efficacy of sodium antimony gluconate and ketoconazole in the treatment of kalaazar - A comparative study. J Comm Dis 1997; 29 - 73-81
28. Sunder S, Rosenkaimer F, Murray HW. Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamme. J Infect Dis 1994, 70 : 659-662.